Login
$MNTR
$0.03 -$0.01 (23.68%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets
Cash and cash equivalents
Investments in securities, fair value
Accounts receivable, net
Accrued interest receivable
Investment in gold commodity, at cost
Royalty income receivable
Other receivable
Note Receivable
Prepaid expenses and other current assets
Total current assets
Property and equipment
Accumulated depreciation and amortization
Property and equipment
Accumulated depreciation and amortization
Property and equipment, net
Other assets
Operating lease right-of-use assets
Finance lease right-of-use assets
Investment in account receivable, net of discount and current portion
Security Deposit
Long-term investments
Goodwill
Intangible property
Royalty interests in the Permian Basin
Accumulated amortization of royalty interests
Intangible property, net
Total other assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable
Accrued salaries and benefits - related party
Accrued expenses
Related Party Loans
Economic injury disaster loan, current portion
Finance lease liability, current portion
Operating lease liability, current portion
Total current liabilities
Long-term liabilities
Accrued salary, retirement, and incentive fee - related party
Economic injury disaster loan, net of current portion
Long-term finance lease liabilities
Operating leases, Long-term liability
Total long-term liabilities
Total liabilities
Shareholders’ equity
Common stock, $0.0001 and $0.0001 par value, 75,000,000 and 75,000,000 shares authorized; 27,589,296 and 21,683,189 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively.
Additional paid in capital
Accumulated deficit
Non-controlling interest
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support